Search for: "Astellas Pharma Inc." Results 41 - 53 of 53
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 May 2018, 4:26 pm by Kevin LaCroix
  Background Astellas Pharma U.S. is a pharmaceutical company and the U.S-based subsidiary of Astellas Pharma, Inc. [read post]
8 Nov 2007, 9:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalIP Think Tank top five's: (IP Think Tank),More on IP law in the virtual world: (VirtualLaw), Interesting times for the Citi brand: (IAM), Velcro has won control of the domain name velcro.biz: (OUT-LAW), The Economic Value of Patent 'Trolls': (IP Think Tank),Industry Trilateral group and the 'global patent application' project: (PatentDocs), Update on the BitTorrent war -… [read post]
10 Jun 2011, 6:22 am by Bexis
Astellas Pharma, US, Inc., 2007 WL 2137782 (E.D. [read post]
1 Dec 2007, 9:00 am
: (Trademark Blog), Short paper on domain name monetization: (Trademark Blog),Comcast puts non-lawyer in charge of IP Strategy: (IAM),Are green technology IP rights owners about to become the new big pharma? [read post]
14 May 2023, 7:07 pm
.'s Shanghai offices, the rad on the Beijing offices of Mintz Group, cyber reviews of Micron Technology, Inc., and the detention of a Japanese employee of Astellas Pharma, Inc., suggests a broader purpose.Business executives who have consulted with Chinese authorities said the government aims to limit the information collected by foreign companies such as auditors, management consultants, and law firms that could influence how the outside world views China. [read post]
21 Sep 2021, 1:25 pm by Tom Lamb
Our law firm is investigating cases for patients who have suffered the Padcev skin side effects Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) as possible drug injury lawsuits to be filed against Astellas Pharma US, Inc., the manufacturer of Padcev. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
5 Jan 2010, 10:56 am by Erin Miller
Opinion below (9th Circuit) Petition for certiorari Brief in opposition Petitioner's reply Docket: 09-335 Title: Astellas Pharma, Inc. v. [read post]
18 May 2009, 5:24 am
: Omnicare, Inc v OHIM, Astellas Pharma GmbH (Class 46) CFI delivers judgment in case concerning ability of designer who assigns business and related IP to another company, to object when the company tries to register his name as a CTM: Elio Fiorucci v OHIM (IPKat) CFI: Good faith irrelevant when selling non-misleading sausages: Alberto Severi, in his own name and representing Cavazzuti e figli SpA, now known as Grandi Salumifici Italiani SpA v Regione Emilia-Romagna… [read post]